Direktorat Registrasi ObatValid

PREGABALIN

BPOM Number: GKL1909324401A1
Approved: 11 May 2026
Expiry: 12 November 2030
Form: Capsule

About This Registration

PREGABALIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1909324401A1. Its current registration status is Valid, with the licence valid until 12 November 2030. The product is registered to IKAPHARMINDO PUTRAMAS TBK. - INDONESIA. BPOM first approved this registration in April 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 3 BLISTER @ 10 KAPSUL
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

IKAPHARMINDO PUTRAMAS TBK. - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 011048469007000
owner
View profile →

Manufacturing Sites

IKAPHARMINDO PUTRAMAS TBK. - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Ingredients (1)

PREGABALIN

Market Intelligence

Owner Portfolio: IKAPHARMINDO PUTRAMAS TBK. - INDONESIA holds 114 BPOM registrations
Manufacturer Scale: IKAPHARMINDO PUTRAMAS TBK. - INDONESIA produces 114 registered products
Registration Age: Registered for 4 months

FDA Cross-Reference

via openFDA

Generic Name: PREGABALIN
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?